0001127602-12-008916.txt : 20120301 0001127602-12-008916.hdr.sgml : 20120301 20120301162836 ACCESSION NUMBER: 0001127602-12-008916 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120228 FILED AS OF DATE: 20120301 DATE AS OF CHANGE: 20120301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERSTEIN DAVID L CENTRAL INDEX KEY: 0001242986 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 12658138 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0304 4 2012-02-28 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001242986 BERSTEIN DAVID L C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 Senior VP, Chief IP Officer Common Stock 2012-02-28 4 M 0 10200 3.90 A 208456 D Common Stock 2012-02-28 4 M 0 1175 4.19 A 209631 D Common Stock 2012-02-28 4 S 0 11375 15.50 D 198256 D Employee Stock Option (Right to Buy) 3.90 2012-02-28 4 M 0 10200 0 D 2003-08-15 2013-08-15 Common Stock 10200 0 D Employee Stock Option (Right to Buy) 4.19 2012-02-28 4 M 0 1175 0 D 2003-06-18 2012-06-18 Common Stock 1175 0 D Shares were acquired upon the exercise of outstanding stock options at $3.90 per share. Shares were acquired upon the exercise of outstanding stock option at $4.19 per share. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011. /s/Edward M. Fitzgerald, Attorney-in-Fact 2012-02-29